Senate Bill 134 of 2021 (Public Act 147 of 2022)

rss | Printer Friendly
Previous Bill      Next Bill

Sponsors

Categories

Crimes: fraud; manufacture, advertisement, sale, or distribution of synthetic urine or adulterant for purposes of defrauding urine drug test; prohibit. Amends 1931 PA 328 (MCL 750.1 - 750.568) by adding sec. 410c.

Documents

Bill Document Formatting Information
Senate Introduced Bill
Introduced bills appear as they were introduced and reflect no subsequent amendments or changes
As Passed by the Senate
The As Passed by the Senate version is the bill, as introduced, that includes any adoped Senate amendments
As Passed by the House
The As Passed by the House version is the bill, as introduced, that includes any adoped House amendments
Senate Concurred Bill
The Concurred Bill is the version passed in identical form by both houses of the Legislature, issues prior to availability of the Enrolled Bill
Public Act
A Public Act is a bill that has become law

Analysis

Senate Fiscal Agency Analysis

SUMMARY OF INTRODUCED BILL IN COMMITTEE (Date Completed: 3-18-21)
This document analyzes SB0134, SB0135
SUMMARY OF BILL REPORTED FROM COMMITTEE (Date Completed: 4-13-21)
This document analyzes SB0134
SUMMARY AS ENACTED (Date Completed: 12-19-22)
This document analyzes SB0134

House Fiscal Agency Analysis

Summary as Passed by the Senate (5/11/2022)
This document analyzes SB0134
Summary as Referred to Second House Committee (6/6/2022)
This document analyzes SB0134
Analysis as Reported from House Committee/Enacted Version (6/30/2022)
This document analyzes SB0134

History

(House actions in lowercase, Senate actions in UPPERCASE)
Note: A page number of 0 indicates that the page number is coming soon
Date Journal Action
2/16/2021 SJ 11 Pg. 161 INTRODUCED BY SENATOR CURTIS S. VANDERWALL
2/16/2021 SJ 11 Pg. 161 REFERRED TO COMMITTEE ON HEALTH POLICY AND HUMAN SERVICES
4/13/2021 SJ 29 Pg. 474 REPORTED FAVORABLY WITH SUBSTITUTE (S-1)
4/13/2021 SJ 29 Pg. 474 REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)
4/15/2021 SJ 31 Pg. 484 REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)
4/15/2021 SJ 31 Pg. 484 SUBSTITUTE (S-1) CONCURRED IN
4/15/2021 SJ 31 Pg. 484 PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1)
4/21/2021 SJ 33 Pg. 513 PASSED ROLL CALL # 95 YEAS 33 NAYS 1 EXCUSED 2 NOT VOTING 0
4/21/2021 HJ 33 Pg. 536 received on 04/21/2021
4/21/2021 HJ 33 Pg. 538 read a first time
4/21/2021 HJ 33 Pg. 538 referred to Committee on Health Policy
5/26/2022 HJ 49 Pg. 824 referred to Committee on Judiciary, with substitute (H-1)
6/07/2022 HJ 52 Pg. 843 reported with recommendation with substitute (H-1)
6/07/2022 HJ 52 Pg. 843 referred to second reading
6/30/2022 HJ 63 Pg. 1060 read a second time
6/30/2022 HJ 63 Pg. 1060 substitute (H-1) adopted
6/30/2022 HJ 63 Pg. 1060 placed on third reading
6/30/2022 HJ 63 Pg. 1060 placed on immediate passage
6/30/2022 HJ 63 Pg. 1060 read a third time
6/30/2022 HJ 63 Pg. 1060 passed; given immediate effect Roll Call # 357 Yeas 96 Nays 10 Excused 0 Not Voting 4
6/30/2022 HJ 63 Pg. 1061 inserted full title
6/30/2022 HJ 63 Pg. 1060 returned to Senate
7/01/2022 SJ 61 Pg. 1234 HOUSE SUBSTITUTE (H-1) CONCURRED IN
7/01/2022 SJ 61 Pg. 1234 ROLL CALL: ROLL CALL # 401 YEAS 36 NAYS 1 EXCUSED 1 NOT VOTING 0
7/01/2022 SJ 61 Pg. 1234 GIVEN IMMEDIATE EFFECT
7/01/2022 SJ 61 Pg. 1234 FULL TITLE AGREED TO
7/01/2022 SJ 61 Pg. 1234 ORDERED ENROLLED
7/20/2022 SJ 62 Pg. 1600 PRESENTED TO GOVERNOR 07/07/2022 11:14 AM
7/20/2022 SJ 62 Pg. 1593 APPROVED BY GOVERNOR 07/19/2022 09:32 AM
7/20/2022 SJ 62 Pg. 1593 FILED WITH SECRETARY OF STATE 07/19/2022 11:54 AM
7/20/2022 SJ 62 Pg. 1593 ASSIGNED PA 0147'22 WITH IMMEDIATE EFFECT